Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Seeger

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Arzneimittel-Forschung|January 1, 1981
Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatographyF Kees, E Strehl, K Seeger, et al.
The American Journal of Dermatopathology|April 19, 2000
Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 casesS R Granter, K Seeger, E Calonje, et al.
European Journal of Clinical Investigation|April 1, 1988
Density and agonist-promoted high and low affinity states of the beta-adrenoceptor on human B- and T-cellsM Griese, U Körholz, D Körholz, et al.
American Journal of Alzheimer'S Disease and Other Dementias|March 27, 2014
Diagnosis of posterior cortical atrophy delayed by coexisting Fuchs' Endothelial Corneal DystrophyDong Y Han, Anne L Shandera-Ochsner, Brian D Bell, et al.
Leukemia|November 22, 1997
Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALLT Taube, K Seeger, B Beyermann, et al.
Leukemia|February 16, 2000
Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemiaC Eckert, O Landt, T Taube, et al.
Cancer Research|April 28, 2001
Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)R Varon, A Reis, G Henze, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporinM Limbert, D Isert, N Klesel, et al.
Clinical Therapeutics|January 1, 1987
Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administrationE E Dagrosa, P Hajdú, V Malerczyk, et al.
Leukemia|July 1, 2006
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemiaH Graf Einsiedel, L Kawan, C Eckert, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Arzneimittel-Forschung|January 1, 1981
Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatographyF Kees, E Strehl, K Seeger, et al.
The American Journal of Dermatopathology|April 19, 2000
Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 casesS R Granter, K Seeger, E Calonje, et al.
European Journal of Clinical Investigation|April 1, 1988
Density and agonist-promoted high and low affinity states of the beta-adrenoceptor on human B- and T-cellsM Griese, U Körholz, D Körholz, et al.
American Journal of Alzheimer'S Disease and Other Dementias|March 27, 2014
Diagnosis of posterior cortical atrophy delayed by coexisting Fuchs' Endothelial Corneal DystrophyDong Y Han, Anne L Shandera-Ochsner, Brian D Bell, et al.
Leukemia|November 22, 1997
Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALLT Taube, K Seeger, B Beyermann, et al.
Leukemia|February 16, 2000
Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemiaC Eckert, O Landt, T Taube, et al.
Cancer Research|April 28, 2001
Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)R Varon, A Reis, G Henze, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporinM Limbert, D Isert, N Klesel, et al.
Clinical Therapeutics|January 1, 1987
Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administrationE E Dagrosa, P Hajdú, V Malerczyk, et al.
Leukemia|July 1, 2006
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemiaH Graf Einsiedel, L Kawan, C Eckert, et al.
Pageof 11